Tarek Nafee MD MMSc (@tarekomarnafee) 's Twitter Profile
Tarek Nafee MD MMSc

@tarekomarnafee

❤️ Fellow @SLUCards | Former Clinical Trials Fellow @BidmcCvi PERFUSE Study Group | Aspiring IC & Clinical Trialist

ID: 921931956992045057

linkhttps://scholar.google.com/citations?hl=en&user=kqHVtr8AAAAJ calendar_today22-10-2017 02:51:22

1,1K Tweet

2,2K Followers

4,4K Following

Rishi Wadhera, MD MPP (@rkwadhera) 's Twitter Profile Photo

12 states did not expand Medicaid under the #ACA Our JAMA Cardiology study led by Andrew Oseran, MD MBA provides a recent snapshot of uninsurance, care access, & #cardiovascular risk factor management for younger adults w/ low income by Medicaid expansion status /1 jamanetwork.com/journals/jamac…

Ron Barbosa MD FACS (@rbarbosa91) 's Twitter Profile Photo

🧵on 'French' and 'Gauge' The 'French' unit of measurement was once known as the 'Charrière', after Joseph-Frédéric-Benoît Charrière, a Swiss knifemaker who moved to France in 1820 and became a manufacturer of surgical instruments. 1 Fr = 1/3 mm. It was renamed because...

🧵on 'French' and 'Gauge'

The 'French' unit of measurement was once known as the 'Charrière', after Joseph-Frédéric-Benoît Charrière, a Swiss knifemaker who moved to France in 1820 and became a manufacturer of surgical instruments.

1 Fr = 1/3 mm.
 
It was renamed because...
Tarek Nafee MD MMSc (@tarekomarnafee) 's Twitter Profile Photo

The Clinical Trials Fellowship at PERFUSE with C. Michael Gibson MD was a period of immense personal & professional growth for me. I highly recommend this immersive, once in a lifetime experience with a giant in the field and an inspirational leader. If you are considering - Apply!

SLU Graduate Medical Education (@slu_gme) 's Twitter Profile Photo

Congrats to our most recent Humanistic Healer award winners - M. Khurram Afzal. "Dr. Afzal's demeanor, professionalism, & willingness to help our team was exceptional & he should be recognized for his great work!” Khurram Afzal MD

Congrats to our most recent Humanistic Healer award winners - M. Khurram Afzal. "Dr. Afzal's demeanor, professionalism, &amp; willingness to help our team was exceptional &amp; he should be recognized for his great work!” <a href="/khurramafzal/">Khurram Afzal MD</a>
SLU Cardiology Fellowship (@slucards) 's Twitter Profile Photo

Love the camaraderie of our fellows. This is what makes us proud 💪🏼 As we warm heartedly welcomed our new fellows Willy Frick Jibran Mirza Tarek Nafee MD MMSc and Somshukla Ghosh, we will soon welcome applications from across the country for #Match2023 American College of Cardiology Missouri ACC

Federico Moccetti, MD (@fmoccetti) 's Twitter Profile Photo

Differentiating VT Form SVT on #ECG can be challenging! We developed a user friendly algorithm based on clinical info and 2 leads (II,aVR). In a clinical validation residents and fellows are as proficient as #EPeeps JACC Journals tinyurl.com/44bfs5kx

Differentiating VT Form SVT on #ECG can be challenging! We developed a user friendly algorithm based on clinical info and 2 leads (II,aVR). In a clinical validation residents and fellows are as proficient as #EPeeps
<a href="/JACCJournals/">JACC Journals</a> 
tinyurl.com/44bfs5kx
David J. Cohen, MD, MSc (@djc795) 's Twitter Profile Photo

1/x Mini-Tweetorial on External Validity vs. Competing Risk. Based on an ongoing discussion with John Mandrola, MD , Alex Sandhu , Gregg Fonarow MD, @mikejohansenmd and others, I have put together this mini-tweetorial on how to think about external validity of trials vs. competing risks.

Mohamad Alkhouli (@adnanalkhouli) 's Twitter Profile Photo

🧵What does the left atrial appendage do? Is it just a nidus for thrombus? A brief review of proposed & proven functions of the LAA👇 #CardioTwitter #EPeeps #MedEd @drpaulfriedman Chet Rihal

SLU Cardiology Fellowship (@slucards) 's Twitter Profile Photo

Late post for #NationalDogDay. These precious #paws have been part of our fellows’ lives and they are now officially #SLUPaws 🐶🐕#DogsOnTwitter. #ACCFIT

SLU Cardiology Fellowship (@slucards) 's Twitter Profile Photo

Our fellows had a very engaging session with Dr Gopinathannair Rakesh Gopinath and Dr Philip Mar learning 🫀 anatomy and it’s implications with interventional, structural and EP procedures. Thank you Abbott Cardiovascular for arranging this. #KCHRI #ACCFIT #EPeeps

Our fellows had a very engaging session with Dr Gopinathannair <a href="/drrakeshg1/">Rakesh Gopinath</a> and Dr Philip Mar learning 🫀 anatomy and it’s implications with interventional, structural and EP procedures. Thank you <a href="/AbbottCardio/">Abbott Cardiovascular</a> for arranging this. #KCHRI #ACCFIT #EPeeps
Sek Kathiresan MD (@skathire) 's Twitter Profile Photo

We're probably all meant to live with an LDL around 30 mg/dl (further evidence) observational data from FOURIER trial Achieved LDL <20 mg/dl (red line) *lowest event rate (L) *lowest all-cause mortality (R) *no safety signals (R) Analysis from @prakritigaba TIMI Study Group

We're probably all meant to live with 
an LDL around 30 mg/dl (further evidence)

observational data from FOURIER trial

Achieved LDL &lt;20 mg/dl (red line)

*lowest event rate (L)
*lowest all-cause mortality (R)
*no safety signals (R)

Analysis from @prakritigaba <a href="/TIMIStudyGroup/">TIMI Study Group</a>
C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile Photo

We found that a new subcutaneously administered 2b3a inhibitor improved patency in #STEMI patients We are now testing the effectiveness of this drug in a phase 3 trial when administered at the time the ambulance arrives at a patient's home

Umair Khalid (@umair2017) 's Twitter Profile Photo

1/ Good teaching hemodynamics case w/ #tweetorial for #ACCFIT #MedTwitter #CardioTwitter 📌Shunt run: RA 74% IVC 70% but -> SVC 85% !!! 😕 Given high SVC sat, serial sats & venogram helped w/ the diagnosis 👇

1/ Good teaching hemodynamics case w/ #tweetorial for #ACCFIT #MedTwitter #CardioTwitter

📌Shunt run: 
RA 74%
IVC 70%
but -&gt; SVC 85% !!! 😕

Given high SVC sat, serial sats &amp; venogram helped w/ the diagnosis 👇
Robert W. Yeh (@rwyeh) 's Twitter Profile Photo

PCI is effective at reducing angina when the target coronary lesion is responsible for angina. Sounds obvious, but bears repeating because of the implications: This is a DIAGNOSTIC problem, not a therapeutic one. We don't have a perfect test linking symptoms to disease.

C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile Photo

Hyperlipidemic patients with high LDL > 100 mg/dl have significant CV benefit from infusion of HDL/ApoA1 infusion after MI, new substudy from AEGIS-II trial shows. Finding biologically plausible and hypothesis generating, requires prospective validation. #ESCCongress